HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1,2,3,5- tetrahydro- 6- methoxy- N- (4- methoxyphenyl)- 5- methyl- 3- oxopyrido(1,2- a)benzimidazole- 4- carboxamide

an anxiolytic agent; structure in first source

Also Known As:

RWJ 53050; RWJ-53050; RWJ53050

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 1,2,3,5-tetrahydro-6-methoxy-N-(4-methoxyphenyl)-5-methyl-3-oxopyrido(1,2-a)benzimidazole-4-carboxamide: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - 1,2,3,5-tetrahydro-6-methoxy-N-(4-methoxyphenyl)-5-methyl-3-oxopyrido(1,2-a)benzimidazole-4-carboxamide: 1

Experts

1.	McKown, Linda A: 1 article (10/2006)
2.	Reitz, Allen B: 1 article (10/2006)
3.	Wu, Wu-Nan: 1 article (10/2006)

Related Diseases

1.	Dehydration (Water Stress) 10/01/2006 - "The formation of RWJ-53050 metabolites are via the 5 pathways: 1. N/O-demethylation, 2. phenylhydroxylation, 3. pyrido-oxidation, 4. dehydration, and 5. conjugation. "